The reported spatial expression of the melanoma signature gene Sox10 (Figure 6G) shows that Sox10+ cells were significantly reduced after MASKv treatment, further supporting that MASKv can have a therapeutic effect on tumors. This evidence concerns the gene SOX10 and melanoma.